Sesen Bio sesenbio.com

Sesen Bio, formerly Eleven Biotherapeutics, is a late-stage company developing next-generation antibody-drug conjugate (ADC) therapies for patients with cancer.

Sesen Bio, formerly Eleven Biotherapeutics, is a late-stage company developing next-generation antibody-drug conjugate (ADC) therapies for patients with cancer.

See All Exits Recent Exits

Phone: 617-444-8550

Fax:

245 First Street
Suite 1800
Cambridge, 02142
Massachusetts, United States

Sesen Bio - Investments & Acquisitions

Show Real Data Sesen Bio Investments
See all Recent Investments
Date Company Round Amount Co-investors
2016-09-21ViventiaAcquired
See all 1 investments